Close Menu

Bill Gates is stepping down as head of Microsoft in less than three months, and he has big plans for how he's going to spend his time, says this post at Wired. At a speech on Monday at the Institute for Systems Biology, Gates told the crowd that he would devote his full energy to his foundation and to encouraging technology and biology to get pharma to develop more drugs for infectious diseases in the developing world.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.